SCHEMBL20501010

SCHEMBL20501010

Nc1ncc(-c2cccc(NC(=O)Nc3ccc(C(F)(F)F)cc3)c2)[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ1A Q9NRL2 1/20 0.54
MTOR P42345 1/20 0.54
KDR P35968 4/20 0.53
SCN9A Q15858 2/20 0.52
SCN4A P35499 1/20 0.52
SCN3A Q9NY46 1/20 0.52
BRAF P15056 2/20 0.52
CDK8 P49336 2/20 0.50
CDK7 P50613 1/20 0.50
CDK6 Q00534 1/20 0.50
EPHX2 P34913 2/20 0.49
FLT3 P36888 2/20 0.49
PLK4 O00444 1/20 0.48
AURKA O14965 1/20 0.48
ROCK2 O75116 1/20 0.48
CHEK2 O96017 1/20 0.48
EGFR P00533 1/20 0.48
NTRK1 P04629 1/20 0.48
LCK P06239 1/20 0.48
FYN P06241 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20500937 0.92 KDR (0.57) KDRSCN9ASCN4ASCN3ABRAF
SCHEMBL20500970 0.91 KDR (0.57) KDRSCN9ASCN4ASCN3ACDK8
SCHEMBL20501054 0.89 CNR1 (0.57) KDRSCN9ASCN4ASCN3AEPHX2
SCHEMBL20501157 0.88 SCN9A (0.57) KDRSCN9ASCN4ASCN3A
SCHEMBL20501030 0.88 SCN9A (0.61) KDRSCN9ASCN4ASCN3ACDK8
SCHEMBL20500966 0.88 SCN9A (0.51) KDRSCN9ASCN4ASCN3ABRAF
SCHEMBL20500958 0.87 SCN4A (0.48) KDRSCN9ASCN4ASCN3ALYN
SCHEMBL20501076 0.87 SCN9A (0.61) KDRSCN9ASCN4ASCN3ABRAF
SCHEMBL20501106 0.87 SCN9A (0.50) KDRSCN9ASCN4ASCN3ACDK8
SCHEMBL20501039 0.85 KDR (0.54) KDRSCN9ASCN4ASCN3ACDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11582970-B2 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth NORTH CAROLINA STATE UNIVERSITY (US) 2023-02-21 US disclosed
US-20220000118-A1 2-AMINOIMIDAZOLE-PHENYL DERIVATIVES USEFUL FOR CONTROLLING MICROBIAL GROWTH NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-01-06 US disclosed
CN-110740645-A 2-aminoimidazole-phenyl derivatives for controlling microbial growth 北卡罗莱纳州立大学 2020-01-31 CN disclosed
WO-2018169752-A1 2-AMINOIMIDAZOLE-PHENYL DERIVATIVES USEFUL FOR CONTROLLING MICROBIAL GROWTH NORTH CAROLINA STATE UNIVERSITY (US) 2018-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11582970-B2 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth DDC, IL4I1, ING2 BAZ1A 1526/4885MTOR 137/4885KDR 2600/4885
US-20220000118-A1 2-AMINOIMIDAZOLE-PHENYL DERIVATIVES USEFUL FOR CONTROLLING MICROBIAL GROWTH DDC, IL4I1, ING2 BAZ1A 1526/4885MTOR 137/4885KDR 2600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.